Z 2347 Z 2347
Pill imprint Z 2347 Z 2347 has been identified as Procainamide hydrochloride 500 mg.
Procainamide is used in the treatment of arrhythmia and belongs to the drug class group I antiarrhythmics. Risk cannot be ruled out during pregnancy.
Procainamide 500 mg is not subject to the Controlled Substances Act.
See also related documents.
Procainamide hydrochloride Images
- Imprint:
-
Z 2347
Z 2347 - Strength:
- 500 mg
- Color:
- Orange & Yellow
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Inactive Ingredients:
- lactose anhydrous
magnesium stearate
methylparaben
pregelatinized starch
propylparaben
silicon dioxide
sodium lauryl sulfate
stearic acid
magnesium silicate
FD&C Yellow No. 6
D&C Yellow No. 10
titanium dioxide
- Drug Class:
- Group I antiarrhythmics
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Teva Pharmaceuticals USA
- National Drug Code (NDC):
- 00172-2347
Advertisement
More Procainamide Hydrochloride resources
- Procainamide (Wolters Kluwer)
- Procainamide Capsules (Wolters Kluwer)
- Procainamide Controlled-Release (Wolters Kluwer)
- procainamide injection (Cerner Multum)
- procainamide Intravenous (Micromedex) - Includes Dosage Information
- Procainamide Hydrochloride (AHFS DI)
- Procainamide (FDA)
- Procainamide capsules (FDA)
- Procainamide Hydrochloride (Wolters Kluwer)
Search Again
